[Principles and Clinical Significance of Insulin-like Growth Factors/somatomedins]

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1990 Oct 17

PMID 2178203

Citations 1

Authors

E Weimann

W Kiess

Affiliations

Soon will be listed here.

Abstract

The Insulin-like Growth Factors (IGFs) or Somatomedins are polypeptide growth factors which are similar to insulin in respect to their aminoacid sequence, structure and biologic activities. The IGFs bind to high affinity receptors which are present on many cells and in many tissues. In the circulation the IGFs are bound to transport (binding) proteins (IGF-BPs). In this review the physiologic role, the basic chemistry and the gene expression of this family of growth factors is summarized systematically. The pathophysiology of growth disorders, diabetes mellitus, malnutrition, liver and kidney disease in relation to the IGFs as well as the therapeutic and diagnostic potentials of these peptides are discussed in detail.

Citing Articles

Growth failure and insulin-like growth factor (IGF-I) in childhood celiac disease.

Eichler I, Frisch H, Granditsch G Klin Wochenschr. 1991; 69(18):825-9.

PMID: 1770750 DOI: 10.1007/BF01649453.

References

Gammeltoft S, Haselbacher G, HUMBEL R, Fehlmann M, Van Obberghen E . Two types of receptor for insulin-like growth factors in mammalian brain. EMBO J. 1985; 4(13A):3407-12. PMC: 554677. DOI: 10.1002/j.1460-2075.1985.tb04097.x. View

Saenger P, LEVINE L, Wiedemann E, Schwartz E, Pareira J, Heinig B . Somatomedin and growth hormone in psychosocial dwarfism. Padiatr Padol Suppl. 1977; (5):1-12. DOI: 10.1007/978-3-7091-8491-2_1. View

OMalley B . Did eucaryotic steroid receptors evolve from intracrine gene regulators?. Endocrinology. 1989; 125(3):1119-20. DOI: 10.1210/endo-125-3-1119. View

Zapf J, Rinderknecht E, HUMBEL R, FROESCH E . Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. Metabolism. 1978; 27(12):1803-28. DOI: 10.1016/0026-0495(78)90267-6. View

Ballard J, Baxter R, BINOUX M, Clemmons D, Drop S, Hall K . On the nomenclature of the IGF binding proteins. Acta Endocrinol (Copenh). 1989; 121(5):751-2. DOI: 10.1530/acta.0.1210751. View

Gluckman P, Butler J, Edgar B, Gunn T . Studies of insulin-like growth factor -I and -II by specific radioligand assays in umbilical cord blood. Clin Endocrinol (Oxf). 1983; 19(3):405-13. DOI: 10.1111/j.1365-2265.1983.tb00014.x. View

Furlanetto R, Underwood L, Van Wyk J, DErcole A . Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 1977; 60(3):648-57. PMC: 372409. DOI: 10.1172/JCI108816. View

Klapper D, Svoboda M, Van Wyk J . Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I. Endocrinology. 1983; 112(6):2215-7. DOI: 10.1210/endo-112-6-2215. View

Shier P, Watt V . Primary structure of a putative receptor for a ligand of the insulin family. J Biol Chem. 1989; 264(25):14605-8. View

10.

Laron Z, Pertzelan A, Karp M, KOWADLO-SILBERGELD A, Daughaday W . Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab. 1971; 33(2):332-42. DOI: 10.1210/jcem-33-2-332. View

11.

Eshet R, Laron Z, Pertzelan A, Arnon R, Dintzman M . Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci. 1984; 20(1):8-11. View

12.

Casella S, Han V, DErcole A, Svoboda M, Van Wyk J . Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites. J Biol Chem. 1986; 261(20):9268-73. View

13.

Merimee T, Zapf J, FROESCH E . Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl J Med. 1983; 309(9):527-30. DOI: 10.1056/NEJM198309013090904. View

14.

Zapf J, Walter H, FROESCH E . Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest. 1981; 68(5):1321-30. PMC: 370928. DOI: 10.1172/jci110379. View

15.

Haselbacher G, Irminger J, Zapf J, ZIEGLER W, HUMBEL R . Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. Proc Natl Acad Sci U S A. 1987; 84(4):1104-6. PMC: 304370. DOI: 10.1073/pnas.84.4.1104. View

16.

Clemmons D, Underwood L, Ridgway E, KLIMAN B, Van Wyk J . Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism. J Clin Endocrinol Metab. 1981; 52(4):731-5. DOI: 10.1210/jcem-52-4-731. View

17.

Hizuka N, Takano K, Tanaka I, Asakawa K, Miyakawa M, Horikawa R . Demonstration of insulin-like growth factor I in human urine. J Clin Endocrinol Metab. 1987; 64(6):1309-12. DOI: 10.1210/jcem-64-6-1309. View

18.

BALA R, Lopatka J, Leung A, McCOY E, McArthur R . Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth. J Clin Endocrinol Metab. 1981; 52(3):508-12. DOI: 10.1210/jcem-52-3-508. View

19.

Tannenbaum G . Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin. Endocrinology. 1981; 108(1):76-82. DOI: 10.1210/endo-108-1-76. View

20.

Draznin B, Burstein P, Heinrich U, Johnson C, Emler C, SCHALCH D . Insulin-like growth factor and its carrier protein in hypopituitary and hypothyroid children and adults. Clin Endocrinol (Oxf). 1980; 12(2):137-42. DOI: 10.1111/j.1365-2265.1980.tb02128.x. View